Sima Ferman - Concepedia

Author

Sima Ferman

Also Known As

Ferman, S, Ferman, Sima Esther, S Ferman, S. Ferman, S.E. Ferman, SIMA FERMAN, Sima E. Ferman, Sima Esther Ferman, Sima Ferman

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional do Câncer Universidade Federal do Rio de Janeiro University of Padua Vall d'Hebron Hospital Universitari Noah's Ark Children's Hospital for Wales

About

Sima Ferman is an author at Instituto Nacional do Câncer specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	822
2	Public Health	2	2	173
3	Health Sciences	1	1	61
4	Social Sciences	1	1	61
5	Cell Biology	1	1	23

Sima Ferman

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, The Lancet Oncology OncologyMetronomic TherapyRms 2005Maintenance ChemotherapyPharmacotherapy	2019	231
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial Gianni Bisogno, Meriel Jenney, Christophe Bergeron, The Lancet Oncology OncologyMedicineDose-intensified DoxorubicinPathologyPharmacotherapy	2018	182
Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries Beatriz de Camargo, Marceli de Oliveira Santos, Marise Souto Rebelo, International Journal of Cancer Epidemiology Of CancerCancer IncidenceCancer RegistrationOncologyAdolescent Medicine	2009	155
Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Soledad Gallego, Ilaria Zanetti, Daniel Orbach, Cancer	2018	80
Mitotane Associated With Cisplatin, Etoposide, and Doxorubicin in Advanced Childhood Adrenocortical Carcinoma Patrícia Zancanella, Mara Albonei Dudeque Pianovski, Brás Heleno de Oliveira, Journal of Pediatric Hematology/Oncology	2006	72
Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer Cristiane de Sá Ferreira-Facio, Cristiane Milito, Vitor Botafogo, PLoS ONE PathologyImmunophenotypingCytopathologyNeuro-oncologyCancer Detection	2013	61
Brainstem gliomas— Retrospective analysis of 86 patients Denis I. Ueoka, Jânio Nogueira, João Carlos S. Campos, Journal of the Neurological Sciences Neuro-oncologyRetrospective AnalysisBrain Tumor BiologyBrain InjuryNeurology	2009	61
Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high‐grade, operable osteosarcomas of the extremities: A report from the Latin <scp>A</scp>merican Group of Osteosarcoma Treatment Andreza Almeida Senerchia, Carla Renata Pacheco Donato Macedo, Sima Ferman, Cancer	2016	52
Metastatic Rhabdomyosarcoma: Results of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study Reineke A. Schoot, Julia Chisholm, Michela Casanova, Journal of Clinical Oncology	2022	51
Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. Nathália Grigorovski, Evandro Lucena, Clarissa Mattosinho, PubMed	2014	50

Page 1